Skip to content Skip to sidebar Skip to footer

By Bill Gates

Advertisements

As we approach World AIDS Day on December 1st, I’ve been reflecting on how far the world has come in the fight against HIV/AIDS. In the early days of the epidemic, an HIV diagnosis was often a death sentence.

Today, we not only have treatments that allow people with HIV to live full, healthy lives—we also have medications that can prevent HIV transmission with up to 99 per cent effectiveness.

But there’s a catch: These drugs, known as PrEP, must be taken every single day—a challenge for many people around the world, especially those who live hours from the nearest clinic or face stigma in their communities. And missing even a single dose means waning protection.

For my latest post on Gates Notes, I dive deeper into these breakthrough innovations and the partnerships making them possible, including the critical work of organizations like the Global Fund and PEPFAR. Twenty years ago, many people believed that delivering HIV treatment at scale in Africa’s poorest regions was impossible. While the world has made remarkable progress since then, these new forms of PrEP could help us take another major step forward in the fight against HIV/AIDS.

About Guide2Uganda

Guide2Uganda (www.guide2uganda.ugis the most comprehensive source of travel information about Uganda that exists on the web, with more content on its cities & towns, accommodation, attractions, events, museums and galleries than any other online guide that currently exists for Uganda; as well as being a dynamic travel news and events driven site with fresh content added daily.

According to WeFollow & Peer Index (that measure online influence), we are among the most influential online media organizations in Uganda. Guide2Uganda was also awarded ‘’Best Destination Website in Uganda’’ by  Jumia Travel Uganda in the 2018 Africa Travel Awards.

Share your events, travel stories & photos with the world via email: info@guide2uganda.ug.

error: Content is protected !!
Verified by MonsterInsights